| Literature DB >> 25316147 |
Sarah El Ghandour, Sami Azar1.
Abstract
Corticosteroid-induced hyperglycemia is a common medical problem which can cause frequent hospitalizations and therefore relates to an increase in morbidity. Metformin, sulfonylureas, thiazolidinediones and insulin are well known available therapies for the treatment of steroid induced hyperglycemia. Incretin based therapies are a newly developing strategies with a considerable importance in the treatment regimen as well. This review aims at discussing the pathophysiology of steroid induced hyperglycemia in addition to the available therapies used for treatment, focusing on incretin therapies.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25316147 DOI: 10.2174/1573399810666141015102900
Source DB: PubMed Journal: Curr Diabetes Rev ISSN: 1573-3998